Evaluation of Safety and Efficacy of Keratin Hair Therapy
Efficacy and Safety of Keratin Hair Therapy on the Health of Hair and Scalp
1 other identifier
interventional
30
1 country
1
Brief Summary
Hair appearance is an important issue for females. Treatment of hair with keratin has been popular among females nowadays. Although chemical hair straightening application has a beneficial effect on hair shafts with the repair of the broken cuticle, some side effects may occur. Therefore, this study aims to study the efficacy and safety of such new non-formaldehyde widely used keratin treatments on hair by assessment of changes of the scalp, hair density, and the morphology, color, and ultrastructure of hair shaft after application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedStudy Start
First participant enrolled
November 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedJanuary 11, 2021
January 1, 2021
5 months
July 22, 2020
January 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change of hair shedding using the Visual analogue scale (VAS)
It will be used to evaluate hair shedding. Hair shedding is scored on a scale of 1-6. Women are asked to look at the scale and point to the photograph that best correlates with the amount of hair shed on an average day. Grades 1-3 are considered normal. Grade 4 is borderline, while Grades 5 and 6 indicate excessive shedding.
Baseline, 2 months, 4 months, 6 months
Change of hair morphology using trichoscope
It will be used to evaluate hair structure and scalp. Hair density/cm 2 and thickness (mm) will be measured in the frontal, temporal and vertex areas in all participants.
Baseline, 2 months, 4 months, 6 months
Change of hair morphology using Transmission Electron Microscopic examination
Randomly selected samples of each group will be fixed in 3% glutaraldehyde for over a period of 4 hours at 4°C and processed to be examined by transmission electron microscope
Baseline, 2 months, 4 months, 6 months
Safety evaluation
to detect any side effects that will be reported either by the patient or by the physician.
at 6 months
Secondary Outcomes (1)
Change of patient satisfaction questionnaire about keratin treatment
Baseline, 2 months, 4 months, 6 months
Study Arms (3)
Group (1): Treatment with keratin cure hair
ACTIVE COMPARATORGroup (1): Patients will be treated with Keratin cure ® hair treatment. It will be applied once with use of a flat iron.
Group (2): Treatment with Qod max keratin hair
ACTIVE COMPARATORGroup (2): Patients will be treated with QOD Max ® keratin hair treatment. It will be applied once with use of a flat iron.
Group (3): Treatment without keratin hair treatment
PLACEBO COMPARATORGroup (3): Patients will be treated without keratin hair treatment, but the same steps of keratin application will be followed.
Interventions
Hair will be treated with 2 different types of keratin in groups 1 \& 2. All steps of keratin application will be done in group 3 without keratin application as a control group.
Eligibility Criteria
You may qualify if:
- The study will include female patients aged between 18 and 55 years, with hair curl types from III to V according to L'Oréal Curl Classification. The Patients will be randomized by simple randomization into 3 groups, 10 patients for each.
You may not qualify if:
- Pregnant and lactating women.
- Patients having hair loss or under treatment of hair loss in last 3 months.
- Patients with previous history of keratin treatment.
- Patients with scalp affection including infection, injury or surgery
- Patients with chronic medical diseases.
- Patients with anemia (hemoglobin level \<10mg/dl) or under its treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, 82524, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Amr Abdelhamed, MD
Faculty of Medicine, Sohag University, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The participants, investigator and the outcome assessor will be blinded as regards the outcome measures evaluation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, Department of Dermatology
Study Record Dates
First Submitted
July 22, 2020
First Posted
July 28, 2020
Study Start
November 15, 2020
Primary Completion
April 1, 2021
Study Completion
June 1, 2021
Last Updated
January 11, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Data will be available within 6 months after finishing the study.
Individual participant data sharing plan will include the study protocol, statistical analysis plan, and the clinical study report.